COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 761: Articles 7601-7610  | Next

Clinical evaluation of an automated, rapid mariPOC(R) antigen test in screening of symptomatics and asymptomatics for SARS-CoV-2 infections
Gunell, M., Rantasarkka, K., Arjonen, R., Sanden, A., Vuorinen, T.
10.1101/2022.04.22.22273686 — Posted: 2022-04-27
Targeting Neutrophils Extracellular Traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Veras, F. P., Gomes, G. F., Silva, B. M., Almeida, C., Silva, C. M., Schneider, A. H., Corneo, E. S., Bonilha, C. S., Batah, S. S., Martins, R. P., Arruda, E., Fabro, A. T., Alves-Filho, J. C. A., Cunha, T. M., Cunha, F. Q.
10.1101/2022.04.27.489676 — Posted: 2022-04-27
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities
Smits, P. D., Gratzl, S., Simonov, M., Nachimuthu, S. K., Goodwin, B. M., Wang, M. D., Althouse, B. M., Stucky, N.
10.1101/2022.04.26.22271727 — Posted: 2022-04-27
Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study
Malahe, S. R. K., Hoek, R. A. S., Dalm, V. A. S. H., Broers, A. E. C., den Hoed, C. M., Manintveld, O. C., Baan, C. C., van Deuzen, C. M., Papageorgiou, G., Bax, H. I., van Kampen, J. J., Hellemons, M. E., Kho, M. M. L., de Vries, R. D., Molenkamp, R., Reinders, M. E. J., Rijnders, B. J. A.
10.1101/2022.04.25.22273197 — Posted: 2022-04-27
Epidemiological behavior of the contamination curve by COVID-19 in Brazil: a time series study
de Morais, T. N. B., Costa, K. T. d. S., Capistrano, G. N., de Andrade, F. B.
10.1101/2022.04.25.22274291 — Posted: 2022-04-27
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco
Zhang, Y., Belayachi, J., Yang, Y., Fu, Q., Rodewald, L., Li, H., Yan, B., Wang, Y., Shen, Y., Yang, Q., Mu, W., Tang, R., Su, C., Xu, T., Obtel, M., Mhayi, A., Razine, R., Abouqal, R., Zhang, Y., Yang, X.
10.1101/2022.04.23.22274112 — Posted: 2022-04-27
Community factors and excess mortality in the COVID-19 pandemic in England, Italy and Sweden
Parkes, B., Stafoggia, M., Fecht, D., Davies, B., Bonander, C., de'Donato, F., Michelozzi, P., Piel, F. B., Strömberg, U., Blangiardo, M.
10.1101/2022.04.26.22274332 — Posted: 2022-04-27
Impact of the additional/booster dose of COVID-19 vaccine against severe disease during the epidemic phase characterized by the predominance of the Omicron variant in Italy, November 2021 - March 2022
Branda, F.
10.1101/2022.04.21.22273567 — Posted: 2022-04-27
Targeted genomic sequencing with probe capture for discovery and surveillance of coronaviruses in bats
Kuchinski, K. S., Loos, K. D., Suchan, D. M., Russell, J. N., Sies, A. N., Kumakamba, C., Muyembe, F., Mbala Kingebeni, P., Ngay Lukusa, I., NKawa, F., Atibu Losoma, J., Makuwa, M., Gillis, A., LeBreton, M., Ayukekbong, J. A., Monagin, C., Joly, D. O., Saylors, K., Wolfe, N. D., Rubin, E. M., Muyembe Tamfum, J. J., Prystajecky, N. A., McIver, D. J., Lange, C. E., Cameron, A. D. S.
10.1101/2022.04.25.489472 — Posted: 2022-04-26
Anti-SARS-Cov-2 S-RBD IgG formed after BNT162b2 vaccination can bind C1q and activate complement
Abu-Humaidan, A. H. A., Ahmad, F. M., Awajan, D., Jarrar, R., Alaridah, N.
10.1101/2022.04.24.489298 — Posted: 2022-04-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).